News
COMMENT: The monthly cost of a private prescription exceeding £300 from next month is worrying news for the half a million ...
With the new gaming bill, Rathee says e-sports will now be a mainstream career option for those with skill and discipline. "This distinction will help accelerate mainstream adoption, as parents, ...
BDCDA alerts traders in Karnataka on Novo Nordisk insulins & semiglutide injections’ pilferage in transit: Nandita ...
BRITAIN has gone fat jab crazy — with sales of Wegovy soaring by more than 2,000 per cent in the past month. Dieters are ...
19h
Money Talks News on MSNWegovy Fallout: How Novo’s Exit Hits Your Wallet and Waistline
Novo Nordisk announced it is cutting ties with telehealth giant Hims & Hers Health, pulling its blockbuster drug Wegovy from ...
The lawsuit alleges civil violations of the Racketeer Influenced and Corrupt Organizations Act, or RICO, the Connecticut ...
21h
TipRanks on MSNMixed options sentiment in Novo Nordisk with shares up 2.79%
Mixed options sentiment in Novo Nordisk (NVO), with shares up $1.54, or 2.79%, near $56.99. Options volume roughly in line with average with 117k ...
Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...
Here are some of the stories Wall Street is watching on Friday, Aug. 22. Stocks and cryptocurrencies surged after Fed Chair ...
A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...
Discover why Hims & Hers Health's subscriber growth, profitability, and telehealth expansion make it a strong buy with a ...
Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results